Join
Live feed
·
PRReleasevia Quantisnow
Vaccinex Inc. logo

Vaccinex to Report Promising New Clinical Data Revealing Pepinemab's Unique Mechanism to Enhance Immunotherapy at Annual Meeting of American Association for Cancer Research (AACR)

ByQuantisnow·Wall Street's wire, on your screen.
VCNX· Vaccinex Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VCNX (Vaccinex Inc.) and more on Quantisnow.